Comparison of the therapeutic effects of Minoxidil 5% solution alone with Flutamide 2% and Minoxidil 5% mixed solution in patients with androgenetic alopecia referring to dermatology clinic of Isfahan university of medical sciences

Document Type : Research Paper


1 dermatology department,Isfahan University of medical sciences

2 professor of dermatology department,skin diseases and leishmaniasis research center,Isfahan university of medical sciences

3 Student of Medicine, Isfahan university of medical sciences, Isfahan, Iran.

4 Assistant professor, Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

5 dermatology resident,Department of dermatology, Skin diseases and leishmaniasis research center,Isfahan university of medical sciences, Isfahan,Iran


Introduction: A special type of alopecia called androgenetic alopecia is one of the most common skin and hair diseases, and topical minoxidil solution is one of the best treatments. Studies have shown that the use of topical 5% minoxidil solution in patients with androgenetic alopecia reduces hair loss, increases patients' satisfaction with recovery and increases hair growth. Also, the therapeutic effects of flutamide in women with hair loss have been shown that flutamide is a very suitable treatment regimen for the treatment of these patients and its low doses are very suitable and have few side effects. Accordingly, the aim of this study was to compare the therapeutic effects of 5% minoxidil solution with the combined solution of minoxidil 5% and flutamide 2% in patients with androgenetic alopecia referring to Isfahan Skin Clinic.
Methods: This study was a randomized double-blind clinical trial that was conducted as a preliminary study from the summer of 1397 to the summer of 1398 in Al-Zahra Hospital. After identifying patients with mild to moderate androgenetic alopecia as a simple coincidence available to 40 people, they were randomly divided into two groups of cases and 20 subjects. Patients in the control group received 5% minoxidil solution, 1 cc each 20 drops 2 times a day, and patients in the combined group received 2% flutamide and 5% minoxidil in the same way for 9 months. The required data were collected based on the checklist. After collecting the data in SPSS software, version 22 was examined at a significance level of 0.05.
Results: There was no significant difference between gender, age, hair thickness in the two groups of case and control (P>0.05), but there was a significant difference between hair thickness in the two groups of case and control after intervention (P<0.05). There was no significant difference between hair thickness in the case and control groups before the intervention (P>0.05), but there was a significant difference after the intervention (P<0.05). There was a significant difference between hair thickness in the case group before and after the intervention (P<0.05), but there was no significant difference in the control group before and after the intervention (P>0.05). There was a significant difference between hair size in the case and control group before and after the intervention (P<0.05). However, the difference between the mean of the control group before and after the intervention does not show much difference. There was a significant difference between patient satisfaction and physician satisfaction in both case and control groups (P<0.05). There was no significant difference between the time of admission in the two groups of case and control (P>0.05).
Conclusion: According to the results of this study and since conducting this study was an introduction to better understanding the therapeutic effects of minoxidil and flutamide in the treatment of androgenetic alopecia and comparing its therapeutic effects in men and women with androgenetic alopecia, so the necessary measures can be taken. He used a combination of these two drug solutions.


  1. Piraccini BM, Alessandrini A. Androgenetic
    alopecia. Giornale italiano di dermatologia e
    venereologia : organo ufficiale, Societa italiana
    di dermatologia e sifilografia. 2014;149(1):15-
    2. Fariba Iraji, Seyed Mohsen Hosseini, Amir
    Hossein Siadat, Mohammad Ali
    Neilforozadeh, Zahramshahdi. Comparison of
    the effectiveness of concomitant use of
    tacrolimus and minoxidil with minoxidil alone
    in the treatment of patients with Alopecia
    3. Ellis JA, Sinclair R, Harrap SB. Androgenetic
    alopecia: pathogenesis and potential for
    therapy. Expert Rev Mol Med. 2002 Nov
    19;4(22):1-11. doi:
    10.1017/S1462399402005112. PMID:
    4. Shahla Babaeinejad Basiri, Effat Khodaeiani,
    Hamideh Harizchi Ghadim. Comparison of the
    effects of 2% progesterone solution with
    topical minoxidil 2% solution in the treatment
    of androgenic hair loss in women.
    5. Firooz A ,Estarabadi AR, Zartab H,
    Hasanzadeh H, Dowlati Y. Classification and
    Scoring of Androgenetic Alopecia (Male and
    Female Pattern). Measuring the Skin. 2016:1-
    6. Hamilton JB. Patterned loss of hair in man:
    types and incidence. Annals of the New York
    Academy of Sciences. 1951;53(3):708-28.
    7. Norwood O. Male pattern baldness:
    classification and incidence. Southern medical
    journal. 1975;68(11):1359-65.
    8. Blume‐Peytavi U, Blumeyer A, Tosti A,
    Finner A, Marmol V, Trakatelli M, et al. S1
    guideline for diagnostic evaluation in
    androgenetic alopecia in men, women and
    adolescents. British Journal of Dermatology.
    9. Adil A, Godwin M. The effectiveness of
    treatments for androgenetic alopecia: a
    systematic review and meta-analysis. Journal
    of the American Academy of Dermatology.
    2017;77(1):136-41. e5 .
    10. Varothai S, Bergfeld WF. Androgenetic
    alopecia: an evidence-based treatment update
    American journal of clinical dermatology.
    11. Goren A, Shapiro J, Roberts J, McCoy J, Desai
    N ,Zarrab Z, et al. Clinical utility and validity
    of minoxidil response testing in androgenetic
    alopecia. Dermatologic therapy.
    12. Rossi A, Cantisani C, Melis L, Iorio A, Scali
    E, Calvieri S. Minoxidil use in dermatology,
    side effects and recent patents. Recent patents
    on inflammation & allergy drug discovery.
    13. Dhurat R, Sukesh M, Avhad G, Dandale A, Pal
    A, Pund P. A randomized evaluator blinded
    study of effect of microneedling in
    androgenetic alopecia: a pilot study .
  2. International journal of trichology.
    14. Schweiger ES, Boychenko O, Bernstein RM.
    Update on the pathogenesis, genetics and
    medical treatment of patterned hair loss.
    Journal of drugs in dermatology: JDD.
    15. Irwig MS. Depressive symptoms and suicidal
    thoughts among former users of finasteride
    with persistent sexual side effects. The Journal
    of clinical psychiatry. 2012;73(9):1220-3.
    16. Irwig MS, Kolukula S. Persistent sexual side
    effects of finasteride for male pattern hair loss.
    The journal of sexual medicine.
    17. Gupta AK, Foley KA. 5% Minoxidil: treatment
    for female pattern hair loss. Skin therapy letter.
    18. Gupta AK, Charrette A. Topical Minoxidil:
    Systematic Review and Meta-Analysis of Its
    Efficacy in Androgenetic Alopecia. Skinmed.
    19. Elks J. The dictionary of drugs: chemical data:
    chemical data, structures and bibliographies:
    Springer; 2014.
    20. Somani N, Turvy D. Hirsutism: an evidencebased treatment update. American journal of
    clinical dermatology. 2014;15(3):247-66.
    21. Farida C, Faiza B. Severe gynecomastia due to
    anti androgens intake: A case report and
    literature review. Indian journal of
    endocrinology and metabolism.
    22. Lehne RA ,Rosenthal L. Pharmacology for
    Nursing Care-E-Book: Elsevier Health
    Sciences; 2014.
    23. Leyden J, Dunlap F, Miller B, Winters P,
    Lebwohl M, Hecker D, et al. Finasteride in the
    treatment of men with frontal male pattern hair
    loss. Journal of the American Academy of
    Dermatology. 1999;40(6):930-7.
    24. Sintov A, Serafimovich S, Gilhar A. New
    topical antiandrogenic formulations can
    25. stimulate hair growth in human bald scalp
    grafted onto mice. Int J Pharm. 2000 Jan
    20;194(1):125-34. doi: 10.1016/s0378-
    5173(99)00359-2. PMID: 10601691.
    26. Canfield D. Photographic documentation of
    hair growth in androgenetic alopecia .
    Dermatologic clinics. 1999;17(2):261-9.
    27. Keaney TC, Pham H, von Grote E, Meckfessel
    MH. Efficacy and Safety of Minoxidil 5%
    Foam in Combination With a Botanical Hair
    Solution in Men With Androgenic Alopecia.
    Journal of drugs in dermatology : JDD.
    28. Paradisi R, Porcu E, Fabbri R, Seracchioli R,
    Battaglia C, Venturoli S. Prospective cohort
    study on the effects and tolerability of
    flutamide in patients with female pattern hair
    loss. The Annals of pharmacotherapy.
    29. Buhl AE, Baker CA, Cietz AJ.
    Minoxidil sulphotransferase activity
    influences the efficacy of Rogaine
    topical solution (TS): enzyme studies
    using scalp and platelets. J Invest
    Dermatol 1994;102:534.